Chris Steele FCOptom, Clinical Editor of Acuity, wants to make 2026 smarter and leaner
The clinical figures that count.
A glance at what’s happening in the world of technology.
Dr Gillian Rudduck MCOptom on the strategic plan for 2025–30.
Adrian O’Dowd examines the pros and cons of optometrists using LWE as a diagnostic tool for dry eye disease.
Medications such as semaglutide and tirzepatide have become popular to treat type 2 diabetes and obesity, but there can be uncommon ocular side effects. Anna Scott asks: what do optometrists need to know?
"The diagnostic challenge of TINU syndrome, particularly when ocular symptoms are subtle or attributed to other causes."
Primary care optometrists are moving beyond sight tests into delivering therapeutic eye care services and becoming the first port of call for eye health, writes Dr Paramdeep Bilkhu MCOptom.
How does selective laser trabeculoplasty work and how do patients experience the procedure? Becky McCall reports.
OCT-A is increasingly valuable for detecting and managing retinal conditions such as nAMD and diabetic retinopathy. Kathy Oxtoby looks at its benefits and the challenges in community optometric practice.
In part one of this two-part series, Sophie Goodchild outlines the essentials all optometrists should know about research studies – from who funds them to how to refer patients – offering an essential guide to clinical trials.
With retail crime on the increase, Kellie Smith looks at how optometry practices can prevent and respond to thefts while staying safe.